| 12:30-12:50 |
Free Communication Session |
|
Chairperson |
TBA
|
| 12:30-12:40 |
A double-blind, randomized, versus-placebo study, in order to evaluate efficacy of the ultra-micronized palmitoylethanolamide in reducing interferonB-1A related side effects in relapsing remitting Multiple Sclerosis |
|
Discussant: Moses Rodriguez, USA
|
|
| 12:40-12:50 | Brain-derived neurotrophic factor (BDNF) enhance therapeutic effects of human adipose stem cells (ADSC) in ALS rat model Hong J. Lee, Korea |
| Discussant: Amos Panet, Israel |
2nd World Congress on NeuroTherapeutics (DDDN)
|